摘要:
A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R A is a group of formula (a): wherein T represents a group of formula (b): wherein Q is , and where R' is a hydrogen or halogen atom or a -CF 3 , OR 4 , NHR 4 , -NHCOR 4 , -NHCONH 2 , NHSO 2 R 4 , CH 2 OR 4 or -CH 2 SO 2 R 4 group: R 2 is a hydrogen or halogen atom or an -OR 4 group; R 3 is a hydrogen or halogen atome; and R 4 is hydrogen, C 1-6 alkyl or benzyl; X' is a bond or -OCH 2 -; X 2 is a group of formula -CR 5 R 6 -CH 2 -A-wherein R 5 and R 6 are independently hydrogen or methyl; and A is a bond, -CH 2 -, or O; T' represents a hydrogen atom or a group of formula (b) as defined above in respect of T, such that T' and T may be the same or different; R C represents a group (a) as defined above in respect of R A , such that R C and R A may be the same or different; provided that when R A and R C each represent a group of formula: wherein R is oH or -O-benzyl; then when A is a bond, -CH 2 - or -0, R' is not -CH 2 OH or NHSO 2 -C 1-4 alkyl; processes for the preparation of such compounds and their use in medicine and agriculture.
摘要:
A compound with hypoglycaemic activity having formula (II) or a pharmaceutically acceptable ammonium or acid addition salt thereof: wherein R' and R 2 are the same or different and represent hydrogen, Ci-6 alkyl, C 1-6 alkoxy, hydroxy or halogen; R 3 and R' are the same or different and represent hydrogen or C 1-6 alkyl; R' represents hydrogen or C 1-6 alkyl; R 6 represents C 1-6 alkyl, phenyl optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl, and C 1-6 alkoxy; or benzyl optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl and C 1-6 alkoxy; or R 5 and R 6 together represent the remaining members of a 5- or 6- membered ring optionally containing an oxygen, sulphur or additional nitrogen atom and being optionally substituted with C 1-6 alkyl, carboxy or C 1-6 alkoxycarbonyl; and R' represents phenyl, optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl and C 1-6 alkoxy, C 1-6 alkoxy carbonyl, C 1-6 alkanoyl, C 1-6 alkyanoyloxy, nitro, hydro, amino, substituted amino, and carboxy.
摘要:
A compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein R A is a group of formula (a): wherein T represents a group of formula (b): wherein Q is , and where
R' is a hydrogen or halogen atom or a -CF 3 , OR 4 , NHR 4 , -NHCOR 4 , -NHCONH 2 , NHSO 2 R 4 , CH 2 OR 4 or -CH 2 SO 2 R 4 group: R 2 is a hydrogen or halogen atom or an -OR 4 group; R 3 is a hydrogen or halogen atome; and R 4 is hydrogen, C 1-6 alkyl or benzyl; X' is a bond or -OCH 2 -; X 2 is a group of formula -CR 5 R 6 -CH 2 -A-wherein R 5 and R 6 are independently hydrogen or methyl; and A is a bond, -CH 2 -, or O; T' represents a hydrogen atom or a group of formula (b) as defined above in respect of T, such that T' and T may be the same or different; R C represents a group (a) as defined above in respect of R A , such that R C and R A may be the same or different; provided that when R A and R C each represent a group of formula: wherein R is oH or -O-benzyl; then when A is a bond, -CH 2 - or -0, R' is not -CH 2 OH or NHSO 2 -C 1-4 alkyl; processes for the preparation of such compounds and their use in medicine and agriculture.
摘要翻译:式(I)的化合物:其中R A为式(a)的基团:其中T表示式(b)的基团:QX 1 - 其中Q是,其中R 1是氢或卤素原子或-CF 3,OR 4,NHR 4,-NHCOR 4,-NHCONH 2, NHSO 2 R 4,CH 2 O 4或-CH 2 SO 2 R 4基团:R 2是氢或卤素原子或-OR 4基团; R 3是氢或卤素原子; 和R 4是氢,C 1-6烷基或苄基; X 1是键或-OCH 2 - ; X 2是式-CR 5 R 6 -CH 2 -A - ,其中R 5和R 6独立地是氢或甲基; 并且A是键,-CH 2 - 或O; T 1表示氢原子或上述关于T定义的式(b)的基团,使得T 1和T可以相同或不同; R C表示如上面关于R aA定义的基团(a),使得R c和R AA可以相同或不同; 条件是当R A和R C各自表示下式的基团时:其中R 2为oH或-O-苄基; 那么当A为键时,-CH 2 - 或-O,R 1不是-CH 2 OH或NHSO 2 -C 1-4烷基; 这些化合物的制备方法及其在医药和农业中的应用。
摘要:
A compound with hypoglycaemic activity having formula (II) or a pharmaceutically acceptable ammonium or acid addition salt thereof: wherein
R' and R 2 are the same or different and represent hydrogen, Ci-6 alkyl, C 1-6 alkoxy, hydroxy or halogen; R 3 and R' are the same or different and represent hydrogen or C 1-6 alkyl; R' represents hydrogen or C 1-6 alkyl; R 6 represents C 1-6 alkyl, phenyl optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl, and C 1-6 alkoxy; or benzyl optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl and C 1-6 alkoxy; or R 5 and R 6 together represent the remaining members of a 5- or 6- membered ring optionally containing an oxygen, sulphur or additional nitrogen atom and being optionally substituted with C 1-6 alkyl, carboxy or C 1-6 alkoxycarbonyl; and R' represents phenyl, optionally substituted with up to 3 groups selected from halogen, C 1-6 alkyl and C 1-6 alkoxy, C 1-6 alkoxy carbonyl, C 1-6 alkanoyl, C 1-6 alkyanoyloxy, nitro, hydro, amino, substituted amino, and carboxy.
摘要:
A class of substituted amino pyridine derivatives are of value in the treatment of diabetes. Some of the compounds also possess hypolipidaemic activity. The compounds are represented by the formula (I):
wherein R 3 is hydrogen, alkyl or an acidic function; R 2 is hydrogen or alkyl; R 4 and R' are hydrogen, alkyl or halogen; Z is hydrogen, phenyl, alkyl or aralkyl; Alk is alkylene and x is 0 or 1; R 1 is optionally substituted phenyl or naphthyl.